Cargando…
Potential drug targets in the kynurenine pathway to treat acute schizophrenia
AIMS: Schizophrenia is a serious developmental psychiatric disorder with a neurodegenerative component that causes marked deterioration in social relationships and ability to work. Present treatments are not satisfactory. Meta-analysis of placebo-controlled studies in acute schizophrenia shows that...
Autores principales: | Malhotra, Ayush, Manowitz, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770233/ http://dx.doi.org/10.1192/bjo.2021.461 |
Ejemplares similares
-
What Is the Evidence for Using Anti-Epileptic Drugs to Treat Agitation and Irritability in Huntington's Disease?
por: Leong, Kok Keong, et al.
Publicado: (2022) -
Different onset patterns of monthly paliperidone palmitate in hospitalised patient diagnosed with schizophrenia
por: Herrera-Sánchez, Javier, et al.
Publicado: (2021) -
Multimorbidity and Polypharmacy in Psychosis: Identifying Potentially Significant Drug Interactions in an Old Age Inpatient Psychiatry Setting
por: Tewari, Abhinav, et al.
Publicado: (2023) -
Buspirone in obsessive-compulsive disorder: a potential dark horse?
por: Garg, Kabir, et al.
Publicado: (2021) -
Adjunct pharmacotherapy for psychotherapy
por: Lochtenberg, Jessica, et al.
Publicado: (2021)